Abstract

The activator protein-1 (AP-1) family transcription factor, JunB, is an important regulator of proliferation, apoptosis, differentiation, and the immune response. In this report, we show that JunB is cleaved in a caspase-dependent manner in apoptotic anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma cell lines and that ectopically expressed JunB is cleaved in murine RAW 264.7 macrophage cells treated with the NALP1b inflammasome activator, anthrax lethal toxin. In both cases, we identify aspartic acid 137 as the caspase cleavage site and demonstrate that JunB can be directly cleaved in vitro by multiple caspases at this site. Cleavage of JunB at aspartic acid 137 separates the N-terminal transactivation domain from the C-terminal DNA binding and dimerization domains, and we show that the C-terminal cleavage fragment retains both DNA binding activity and the ability to interact with AP-1 family transcription factors. Furthermore, this fragment interferes with the binding of full-length JunB to AP-1 sites and inhibits AP-1-dependent transcription. In summary, we have identified and characterized a novel mechanism of JunB post-translational modification and demonstrate that the C-terminal JunB caspase cleavage product functions as a potent inhibitor of AP-1-dependent transcription.

Highlights

  • The JunB transcription factor is a key mediator of proliferation, apoptosis, differentiation, and the immune response

  • We show that JunB is cleaved in a caspase-dependent manner in apoptotic anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma cell lines and that ectopically expressed JunB is cleaved in murine RAW 264.7 macrophage cells treated with the NALP1b inflammasome activator, anthrax lethal toxin

  • The Electrophoretic Mobility of JunB Is Altered in Staurosporine- and Doxorubicin-treated ALKϩ ALCL Cell Lines—In performing experiments to examine whether JunB protects ALKϩ ALCL cell lines from apoptosis, we observed that treatment of Karpas 299 and SUP-M2 cells with staurosporine altered the electrophoretic mobility of the anti-JunB immunoreactive bands (Fig. 1A)

Read more

Summary

Background

The JunB transcription factor is a key mediator of proliferation, apoptosis, differentiation, and the immune response. We show that JunB is cleaved in a caspase-dependent manner in apoptotic anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma cell lines and that ectopically expressed JunB is cleaved in murine RAW 264.7 macrophage cells treated with the NALP1b inflammasome activator, anthrax lethal toxin In both cases, we identify aspartic acid 137 as the caspase cleavage site and demonstrate that JunB can be directly cleaved in vitro by multiple caspases at this site. Caspase-mediated Cleavage of JunB binding domains, and we show that the C-terminal JunB cleavage product retains the ability to bind DNA and associate with AP-1 family proteins In this regard, overexpression of this fragment: (i) interferes with the ability of full-length JunB to bind an AP-1 target DNA sequence and (ii) inhibits transcription driven by an AP-1-dependent luciferase reporter. Our findings reveal that JunB is cleaved by caspases in apoptotic and inflammasome-stimulated cells and that this cleavage generates a fragment that can function as an inhibitor of AP-1-dependent transcription

EXPERIMENTAL PROCEDURES
D Karpas 299
RESULTS
E Caspase 3
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call